Skip to content
OpenCapital
Get started

Medtronic MDT Cash & Equivalents

Cash & Equivalents at other companies

Abbott logo
AbbottABT
$5.1B-26.6%
TFX
TeleflexTFX
$329.55M+16.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$20.42B+9.9%
Stryker logo
StrykerSYK
$2.88B+24.1%
Artivion logo
ArtivionAORT
$55.76M+47.9%
CONMED logo
CONMEDCNMD
$37.33M+10.0%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$111.21B-6.1%
Enterprise value$138.47B-5.1%
P/E23.2×-2.2×
P/S3.1×-0.5×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's cash & equivalents?
Medtronic (MDT) reported cash & equivalents of $1.95B in Q1 2026.
How has Medtronic's cash & equivalents changed year-over-year?
Medtronic's cash & equivalents decreased by 12.1% year-over-year, from $2.22B to $1.95B.
What is the long-term trend for Medtronic's cash & equivalents?
Over 5 years (2021 to 2026), Medtronic's cash & equivalents has grown at a -11.5% compound annual growth rate (CAGR), from $3.59B to $1.95B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.